nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.134	0.172	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.134	0.172	CbGbCtD
Cyclophosphamide—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.101	0.129	CbGbCtD
Cyclophosphamide—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0968	0.124	CbGbCtD
Cyclophosphamide—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0812	0.104	CbGbCtD
Cyclophosphamide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0675	0.0864	CbGbCtD
Cyclophosphamide—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0655	0.0839	CbGbCtD
Cyclophosphamide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0617	0.079	CbGbCtD
Cyclophosphamide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0392	0.0503	CbGbCtD
Cyclophosphamide—Lung fibrosis interstitial—Cyclosporine—focal segmental glomerulosclerosis	0.0149	0.0682	CcSEcCtD
Cyclophosphamide—Thrombotic microangiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0627	CcSEcCtD
Cyclophosphamide—Wound—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0542	CcSEcCtD
Cyclophosphamide—Posterior reversible encephalopathy syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0479	CcSEcCtD
Cyclophosphamide—Haemolytic uraemic syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00789	0.036	CcSEcCtD
Cyclophosphamide—Acute respiratory distress syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0066	0.0301	CcSEcCtD
Cyclophosphamide—Nephrotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.0247	CcSEcCtD
Cyclophosphamide—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00529	0.0241	CcSEcCtD
Cyclophosphamide—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.0236	CcSEcCtD
Cyclophosphamide—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.0225	CcSEcCtD
Cyclophosphamide—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.0225	CcSEcCtD
Cyclophosphamide—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.022	CcSEcCtD
Cyclophosphamide—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.0216	CcSEcCtD
Cyclophosphamide—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.017	CcSEcCtD
Cyclophosphamide—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.017	CcSEcCtD
Cyclophosphamide—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.0165	CcSEcCtD
Cyclophosphamide—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0137	CcSEcCtD
Cyclophosphamide—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0122	CcSEcCtD
Cyclophosphamide—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.0121	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0111	CcSEcCtD
Cyclophosphamide—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0111	CcSEcCtD
Cyclophosphamide—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0104	CcSEcCtD
Cyclophosphamide—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0104	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0102	CcSEcCtD
Cyclophosphamide—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00921	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00895	CcSEcCtD
Cyclophosphamide—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00889	CcSEcCtD
Cyclophosphamide—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00871	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00865	CcSEcCtD
Cyclophosphamide—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00853	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00848	CcSEcCtD
Cyclophosphamide—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00826	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00801	CcSEcCtD
Cyclophosphamide—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00773	CcSEcCtD
Cyclophosphamide—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00764	CcSEcCtD
Cyclophosphamide—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00747	CcSEcCtD
Cyclophosphamide—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00711	CcSEcCtD
Cyclophosphamide—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00682	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00656	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00653	CcSEcCtD
Cyclophosphamide—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0065	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00644	CcSEcCtD
Cyclophosphamide—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00638	CcSEcCtD
Cyclophosphamide—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00635	CcSEcCtD
Cyclophosphamide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0061	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00605	CcSEcCtD
Cyclophosphamide—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.006	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00597	CcSEcCtD
Cyclophosphamide—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00585	CcSEcCtD
Cyclophosphamide—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00485	CcSEcCtD
Cyclophosphamide—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00481	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00473	CcSEcCtD
Cyclophosphamide—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000984	0.00449	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000975	0.00445	CcSEcCtD
Cyclophosphamide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.00442	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00095	0.00434	CcSEcCtD
Cyclophosphamide—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.00432	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00431	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00431	CcSEcCtD
Cyclophosphamide—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00429	CcSEcCtD
Cyclophosphamide—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00429	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000937	0.00428	CcSEcCtD
Cyclophosphamide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000919	0.00419	CcSEcCtD
Cyclophosphamide—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00087	0.00397	CcSEcCtD
Cyclophosphamide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00396	CcSEcCtD
Cyclophosphamide—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000865	0.00395	CcSEcCtD
Cyclophosphamide—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000865	0.00395	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.00393	CcSEcCtD
Cyclophosphamide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00381	CcSEcCtD
Cyclophosphamide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00368	CcSEcCtD
Cyclophosphamide—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00366	CcSEcCtD
Cyclophosphamide—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000776	0.00354	CcSEcCtD
Cyclophosphamide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000773	0.00353	CcSEcCtD
Cyclophosphamide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.00349	CcSEcCtD
Cyclophosphamide—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000738	0.00337	CcSEcCtD
Cyclophosphamide—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000724	0.0033	CcSEcCtD
Cyclophosphamide—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00071	0.00324	CcSEcCtD
Cyclophosphamide—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.00322	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.00319	CcSEcCtD
Cyclophosphamide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000696	0.00318	CcSEcCtD
Cyclophosphamide—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000692	0.00316	CcSEcCtD
Cyclophosphamide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000679	0.0031	CcSEcCtD
Cyclophosphamide—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.00308	CcSEcCtD
Cyclophosphamide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.003	CcSEcCtD
Cyclophosphamide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00298	CcSEcCtD
Cyclophosphamide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.00297	CcSEcCtD
Cyclophosphamide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00293	CcSEcCtD
Cyclophosphamide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00293	CcSEcCtD
Cyclophosphamide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00293	CcSEcCtD
Cyclophosphamide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00289	CcSEcCtD
Cyclophosphamide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00283	CcSEcCtD
Cyclophosphamide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.00281	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.00281	CcSEcCtD
Cyclophosphamide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000611	0.00279	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.00275	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00271	CcSEcCtD
Cyclophosphamide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000586	0.00267	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00256	CcSEcCtD
Cyclophosphamide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000552	0.00252	CcSEcCtD
Cyclophosphamide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000548	0.0025	CcSEcCtD
Cyclophosphamide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00244	CcSEcCtD
Cyclophosphamide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00242	CcSEcCtD
Cyclophosphamide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.0024	CcSEcCtD
Cyclophosphamide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.0024	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00231	CcSEcCtD
Cyclophosphamide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00223	CcSEcCtD
Cyclophosphamide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000486	0.00222	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00207	CcSEcCtD
Cyclophosphamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.00201	CcSEcCtD
Cyclophosphamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00198	CcSEcCtD
Cyclophosphamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00192	CcSEcCtD
Cyclophosphamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000407	0.00186	CcSEcCtD
Cyclophosphamide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.00178	CcSEcCtD
Cyclophosphamide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.00177	CcSEcCtD
Cyclophosphamide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.00177	CcSEcCtD
Cyclophosphamide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000385	0.00176	CcSEcCtD
Cyclophosphamide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00167	CcSEcCtD
